The article was retracted due to significant integrity concerns regarding multiple figures showing unexpected similarities with previous publications from unrelated author groups.
Zhu J, Zhang X, Xie H, Wang Y, Zhang X, Lin Z. J Inflamm Res. 2021;14: 39453958. https://doi.org/10.2147/JIR.S304520 We, the Editor and Publisher of Journal of Inflammation Research have retracted the published article. After publication, concerns were raised by a third party in 2023 regarding the integrity of Figures 4 and 7 of the article. Further investigation conducted by the Journal and Publisher identified significant integrity concerns in Figures 1, 4, 5, 6 and 7 of the article due to unexpected similarities with multiple previous publications from unrelated author groups. When approached for an explanation, the authors did not respond to the queries raised by the Journal and Publisher. As verifying the validity of published work is core to the integrity of the scholarly record, we are therefore, retracting the article. The corresponding author has been informed. We have been informed in our decision-making by our editorial policies and the COPE guidelines. The retracted articles will remain online to maintain the scholarly record, but they will be digitally watermarked on each page as Retracted.
Zhu et al. (Fri,) conducted a other in Doxorubicin Cardiotoxicity. The article was retracted due to significant integrity concerns regarding multiple figures showing unexpected similarities with previous publications from unrelated author groups.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: